The Use of Epidermal Growth Factor Receptor Type 2-Targeting Tyrosine Kinase Inhibitors in the Management of Epidermal Growth Factor Receptor Type 2-Positive Gastric Cancer: A Narrative Review

Gastric cancer (GC), including gastroesophageal junction cancer (GEJC), continues to be one of the most frequently diagnosed neoplasms globally. Moreover, GC/GEJC is a principal cause of neoplasm-related fatalities. Early-stage GC/GEJC has a favorable five-year overall survival (OS) rate with surgic...

Descripción completa

Detalles Bibliográficos
Autores principales: AlMazmomy, Asim M, Al-Hayani, Majed M, Alomari, Mohammed, Bazi, Abdulrahman G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
General Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942496/
https://www.ncbi.nlm.nih.gov/pubmed/31938588
http://dx.doi.org/10.7759/cureus.6295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942496/
https://www.ncbi.nlm.nih.gov/pubmed/31938588
http://dx.doi.org/10.7759/cureus.6295

Ejemplares similares